Skip to main content
Log in

Effects of common ophthalmic preservatives on ocular health

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Preservatives are an important component of ophthalmic preparations, providing antimicrobial activity in the bottle and preventing decomposition of active drug. Often underrecognized, however, are the significant cytotoxic effects of preservatives associated with long-term therapy and especially use of multiple preserved drugs. The most common preservatives in ophthalmic preparations for glaucoma and surface eye disease—benzalkonium chloride (BAK), chlorobutanol, sodium perborate, and stabilized oxychloro complex (SOC)—were reviewed. Compared with other preservatives, SOC caused the least amount of damage to rabbit corneal epithelial cells. BAK has demonstrated cytotoxic effects in cell culture, as well as in animal and human studies. Physicians should consider treatment with new-generation preparations containing low-risk preservatives such as SOC, especially in patients receiving multiple ophthalmic medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR. Microbial contamination of in-use ocular medications.Arch Ophthalmol. 1992;110:82–85.

    PubMed  CAS  Google Scholar 

  2. Tripathi BJ, Tripathi RC, Kolli SP. Cytotoxicity of ophthalmic preservatives on human corneal epithelium.Lens Eye Toxicol Res. 1992;9:361–375.

    CAS  Google Scholar 

  3. Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C. Comparison of the effects of pre served and unpreserved formulations of timolol on the ocular surface of albino rabbits.Ophthalmic Res. 2000;32:3–8.

    Article  PubMed  CAS  Google Scholar 

  4. Gasset AR, Ishii Y, Kaufman HE, Miller T. Cytotoxicity of ophthalmic preservatives.Am J Ophthalmol. 1974;78:98–105.

    PubMed  CAS  Google Scholar 

  5. Berdy GJ, Abelson MB, Smith LM, George MA. Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects.Arch Ophthalmol. 1992;110:528–532.

    PubMed  CAS  Google Scholar 

  6. Debbasch C, Rat P, Warnet J-M, De Saint Jean M, Baudouin C, Pisella P-J. Evaluation of the toxici ty of benzalkonium chloride on the ocular surface.J Toxicol Cutan Ocul Toxicol. 2000;19:105–115.

    CAS  Google Scholar 

  7. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface.Curr Opin Ophthalmol. 1996;7:80–86.

    Article  PubMed  CAS  Google Scholar 

  8. Baudouin C. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglauco matous drugs?Int J Clin Pharmacol Res. 1996;16:29–41.

    PubMed  CAS  Google Scholar 

  9. Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication, I: the conjunctival cell profile.Arch Ophthalmol. 1994;112:1437–1445.

    PubMed  CAS  Google Scholar 

  10. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglauco ma drugs on the conjunctiva and Tenon’s capsule in glaucomatous patients.Ophthalmology. 1989;96:327–335.

    PubMed  CAS  Google Scholar 

  11. Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man.Br J Ophthalmol. 1975;59:667–669.

    Article  PubMed  CAS  Google Scholar 

  12. Spickett C.Studies of Cellular Responses to Purite and Other Preservatives. Strathclyde, UK: University of Strathclyde; 2001.

    Google Scholar 

  13. Block SS.Disinfection, Sterilization, and Preservation. Malvern, Pa: Lea & Febiger; 1991.

    Google Scholar 

  14. Kreiner C. Biochemical aspects of ophthalmic preservatives.Contacto. 1979;Nov:10-14.

    Google Scholar 

  15. Grant WM, Schuman JS.Toxicology of the Eye. Springfield, Ill: Charles C Thomas; 1990.

    Google Scholar 

  16. Grant R, Ajello M, Vlass E. Salt water or high tech? A look at two new rinsing solutions for contact lenses.Optician. 1996;212:38–41.

    Google Scholar 

  17. Masschelein WJ, Rice RG.Chlorine Dioxide. Chemistry and Environmental Impact of Oxychlorine Compounds. Ann Arbor, Mich: Ann Arbor Science Publishers; 1979.

    Google Scholar 

  18. Rozen S, Abelson M, Giovanoni A, Welch D. Assessment of the comfort and tolerance of 0.5% carboxymethylcellulose preserved with Purite (Refresh Tears) in dry eye sufferers.Invest Ophthalmol Vis Sci. 1998;39(4):S451.

    Google Scholar 

  19. Vaughan JS, Porter DA. A new in vitro method for assessing the potential toxicity of soft contact lens care solutions.CLAO J. 1993;19:54–57.

    PubMed  CAS  Google Scholar 

  20. Paugh JR, Brennan NA, Efron N. Ocular response to hydrogen peroxide.Am J Optom Physiol Opt. 1988;65:91–98.

    PubMed  CAS  Google Scholar 

  21. Seiler JP. The mutagenic activity of sodium perborate.Mutat Res. 1989;224:219–227.

    Article  PubMed  CAS  Google Scholar 

  22. Campagna P, Macri A, Rolando M, Calabria G. Chronic topical eye preservative-free beta-blocker therapy effect on the ocular surface in glaucomatous patients.Acta Ophthalmol Scand Suppl. 1997;224:53.

    PubMed  Google Scholar 

  23. De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM, Baudouin C. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells.Curr Eye Res. 2000;20:85–94.

    Article  PubMed  Google Scholar 

  24. Yalvac IS, Gedikoglu G, Karagoz Y, et al. Effects of antiglaucoma drugs on ocular surface.Acta Ophthalmol Scand. 1995;73:246–248.

    PubMed  CAS  Google Scholar 

  25. Turacli E, Budak K, Kaur A, Mizrak B, Ekinci C. The effects of long-term topical glaucoma medication on conjunctival impression cytology.Int Ophthalmol. 1997;21:27–33.

    Article  PubMed  CAS  Google Scholar 

  26. Arici MK, Arici DS, Topalkara A, Guler C. Adverse effects of topical antiglaucoma drugs on the ocular surface.Clin Exp Ophthalmol. 2000;28:113–117.

    Article  CAS  Google Scholar 

  27. Gobbels M, Spitznas M. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears.Ophthalmology. 1992;99:873–878.

    PubMed  CAS  Google Scholar 

  28. Holly FJ. Surface chemical evaluation of artificial tears and their ingredients, II: interaction with a superficial lipid layer.Contact Lens. 1978;4:52–65.

    CAS  Google Scholar 

  29. Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.Br J Ophthalmol. 1998;82:39–42.

    Article  PubMed  CAS  Google Scholar 

  30. Tomlinson A, Trees GR. Effect of preservatives in artificial tear solutions on tear film evaporation.Ophthalmic Physiol Opt. 1991;11:48–52.

    PubMed  CAS  Google Scholar 

  31. Gupta M, Majumdar DK. Effect of concentration, pH, and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops.Indian J Exp Biol. 1997;35:844–849.

    PubMed  CAS  Google Scholar 

  32. Fassihi AR, Naidoo NT. Irritation associated with tear-replacement ophthalmic drops. A pharmaceutical and subjective investigation.S Afr Med J. 1989;75:233–235.

    PubMed  CAS  Google Scholar 

  33. Tripathi BJ, Tripathi RC. Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro.Lens Eye Toxicol Res. 1989;6:395–403.

    CAS  Google Scholar 

  34. Collin HB. Ultrastructural changes to corneal stromal cells due to ophthalmic preservatives.Acta Ophthalmol (Copenh). 1986;64:72–78.

    Article  CAS  Google Scholar 

  35. Burstein NL, Klyce SD. Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium.Invest Ophthalmol Vis Sci. 1977;16:899–911.

    PubMed  CAS  Google Scholar 

  36. Burstein N. Corneal cytotoxicity of topically applied drugs, vehicles, and preservatives.Surv Ophthalmol. 1980;25:15.

    Article  PubMed  CAS  Google Scholar 

  37. Doughty MJ. Twice-daily use of a chlorobutanol-preserved artificial tear on rabbit corneal epithelium assessed by scanning electron microscopy.Ophthalmic Physiol Opt. 1992;12:457–466.

    PubMed  CAS  Google Scholar 

  38. Lazarus HM, Imperia PS, Botti RE, Mack RJ, Lass JH. An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents.Lens Eye Toxicol Res. 1989;6:59–85.

    CAS  Google Scholar 

  39. Way WA, Matsumoto S, Apel LJ, Wiese A, Tarlo K, Vehige J. Purite™ as a non-disruptive preservative for lubricating eye drop solutions in comparison to alternative preservatives.Invest Ophthalmol Vis Sci. 2001;42:S39.

    Google Scholar 

  40. Walters TR, Batoosingh AL. 12-Month evaluation of brimonidine-Purite compared with brimonidine in patients with glaucoma or ocular hypertension.Invest Ophthalmol Vis Sci. 2001; 42:S558.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Noecker, R. Effects of common ophthalmic preservatives on ocular health. Adv Therapy 18, 205–215 (2001). https://doi.org/10.1007/BF02853166

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02853166

Keywords

Navigation